Completed NA INTERVENTIONAL 1-arm NCT03412604

Effect of Modulating Gamma Oscillations Using tACS

Effect of Modulating Gamma Oscillations by Transcranial Alternating Current Stimulation on Brain Structure and Function in Humans

Sponsor: Defense Advanced Research Projects Agency

Conditions Alzheimer Disease

Interventions Transcranial Alternating Current Stimulation (tACS)

Updated 10 times since 2018 Last updated: Aug 18, 2022 Started: Aug 2, 2018 Primary completion: May 7, 2019 Completion: Sep 15, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03412604, this NA trial focuses on Alzheimer Disease and remains completed. Sponsored by Defense Advanced Research Projects Agency, it has been updated 10 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2022 — Jul 2024 [monthly]

Completed NA
Mar 2022 — Sep 2022 [monthly]

Completed NA
Jun 2021 — Mar 2022 [monthly]

Completed NA

Status: Recruiting → Completed

▶ Show 5 earlier versions

Jan 2021 — Jun 2021 [monthly]

Recruiting NA
Feb 2020 — Jan 2021 [monthly]

Recruiting NA
Oct 2018 — Feb 2020 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jun 2018 — Oct 2018 [monthly]

Not Yet Recruiting NA
Feb 2018 — Jun 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Defense Advanced Research Projects Agency
Massachusetts General Hospital

Data source: Massachusetts General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States